This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.48% per year. These returns cover a period from January 1, 1988 through May 5, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Image: Bigstock
New Strong Buy Stocks for June 4th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
BioCryst Pharmaceuticals (BCRX - Free Report) : This company which is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections, has seen the Zacks Consensus Estimate for its next year earnings increasing 83.3% over the last 60 days.
BioCryst Pharmaceuticals, Inc. Price and Consensus
BioCryst Pharmaceuticals, Inc. price-consensus-chart | BioCryst Pharmaceuticals, Inc. Quote
OptimizeRx (OPRX - Free Report) : This company which provides consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products, has seen the Zacks Consensus Estimate for its current year earnings increasing 27.5% over the last 60 days.
OptimizeRx Corp. Price and Consensus
OptimizeRx Corp. price-consensus-chart | OptimizeRx Corp. Quote
Bridgewater Bancshares (BWB - Free Report) : This company which provides personal and commercial banking products and services to commercial real estate investors, small business entrepreneurs and high-net-worth individuals, has seen the Zacks Consensus Estimate for its current year earnings increasing 11.7% over the last 60 days.
Bridgewater Bancshares, Inc. Price and Consensus
Bridgewater Bancshares, Inc. price-consensus-chart | Bridgewater Bancshares, Inc. Quote
Palomar Holdings (PLMR - Free Report) : This rapidly growing and profitable company focused on the provision of catastrophe insurance for personal and commercial property, has seen the Zacks Consensus Estimate for its current year earnings increasing 4.6% over the last 60 days.
Palomar Holdings, Inc. Price and Consensus
Palomar Holdings, Inc. price-consensus-chart | Palomar Holdings, Inc. Quote
Ferrari (RACE - Free Report) : This company which is engaged in designing, manufacturing and selling sports cars, has seen the Zacks Consensus Estimate for its current year earnings increasing 4.4% over the last 60 day.
Ferrari N.V. Price and Consensus
Ferrari N.V. price-consensus-chart | Ferrari N.V. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.